{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:16:05Z","timestamp":1793643365477,"version":"4.5.1"},"reference-count":46,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"abstract":"<jats:p>BACKGROUND. Congenital West Nile virus (WNV) infection was first described in a single case in 2002. The proportion of maternal WNV infections resulting in congenital infection and clinical consequences of such infections are unknown.<\/jats:p>\n                  <jats:p>METHODS. In 2003 and 2004, women in the United States who acquired WNV infection during pregnancy were reported to the Centers for Disease Control and Prevention by state health departments. Data on pregnancy outcomes were collected. One of the maternal WNV infections was identified retrospectively after the infant was born. Maternal sera, placenta, umbilical cord tissue, and cord serum were tested for WNV infection by using serologic assays and reverse-transcription polymerase chain reaction. Infant health was assessed at delivery and through 12 months of age.<\/jats:p>\n                  <jats:p>RESULTS. Seventy-seven women infected with WNV during pregnancy were clinically followed in 16 states. A total of 71 women delivered 72 live infants; 4 women had miscarriages, and 2 had elective abortions. Of the 72 live infants, 67 were born at term, and 4 were preterm; gestational age was unknown for 1. Of 55 live infants from whom cord serum was available, 54 tested negative for anti-WNV IgM. One infant born with umbilical hernia and skin tags had anti-WNV IgM in cord serum but not in peripheral serum at age 1 month. An infant who had no anti-WNV IgM in cord blood, but whose mother had WNV illness 6 days prepartum, developed WNV meningitis at age 10 days. Another infant, whose mother had acute WNV illness at delivery, was born with a rash and coarctation of the aorta and had anti-WNV IgM in serum at 1 month of age; cord serum was not available. A fourth infant, whose mother had onset of WNV illness 3 weeks prepartum that was not diagnosed until after delivery, had WNV encephalitis and underlying lissencephaly detected at age 17 days and subsequently died; cord serum was not available. The following major malformations were noted among live-born infants: aortic coarctation (n = 1); cleft palate (n = 1); Down syndrome (n = 1); lissencephaly (n = 1); microcephaly (n = 2); and polydactyly (n = 1). One infant had glycogen storage disease type 1. Abnormal growth was noted in 8 infants.<\/jats:p>\n                  <jats:p>CONCLUSIONS. Of 72 infants followed to date in 2003 and 2004, almost all seemed normal, and none had conclusive laboratory evidence of congenital WNV infection. Three infants had WNV infection that could have been congenitally acquired. Seven infants had major malformations, but only 3 of these had defects that could have been caused by maternal WNV infection based on the timing of the infections and the sensitive developmental period for the specific malformations, and none had any conclusive evidence of WNV etiology. However, the sensitivity and specificity of IgM testing of cord blood to detect congenital WNV infection are currently unknown, and congenital WNV infection among newborns with IgM-negative serology cannot be ruled out. Prospective studies comparing pregnancy outcomes of WNV-infected and -uninfected women are needed to better define the outcomes of WNV infection during pregnancy.<\/jats:p>","DOI":"10.1542\/peds.2005-2024","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T14:23:43Z","timestamp":1141223023000},"page":"e537-e545","source":"Crossref","is-referenced-by-count":183,"title":["Birth Outcomes Following West Nile Virus Infection of Pregnant Women in the United States: 2003-2004"],"prefix":"10.1542","volume":"117","author":[{"given":"Daniel R.","family":"O'Leary","sequence":"first","affiliation":[{"name":"Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, US Public Health Service, Department of Health and Human Services, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Kuhn","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, US Public Health Service, Department of Health and Human Services, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Kniss","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, US Public Health Service, Department of Health and Human Services, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison F.","family":"Hinckley","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, US Public Health Service, Department of Health and Human Services, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja A.","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. John","family":"Pape","sequence":"additional","affiliation":[{"name":"Colorado Department of Public Health and Environment, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon K.","family":"Kightlinger","sequence":"additional","affiliation":[{"name":"South Dakota Department of Health, Pierre, South Dakota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brady D.","family":"Beecham","sequence":"additional","affiliation":[{"name":"Nebraska Health and Human Services System, Lincoln, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy K.","family":"Miller","sequence":"additional","affiliation":[{"name":"North Dakota Department of Health, Bismarck, North Dakota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Neitzel","sequence":"additional","affiliation":[{"name":"Minnesota Department of Health, St Paul, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Michaels","sequence":"additional","affiliation":[{"name":"Louisiana Department of Health and Hospitals, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant L.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, US Public Health Service, Department of Health and Human Services, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Lanciotti","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, US Public Health Service, Department of Health and Human Services, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Hayes","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, US Public Health Service, Department of Health and Human Services, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,3,1]]},"reference":[{"key":"2021120820135731100_R1","doi-asserted-by":"crossref","unstructured":"Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med.\u20082001;344:1807\u20131814","DOI":"10.1056\/NEJM200106143442401"},{"key":"2021120820135731100_R2","doi-asserted-by":"crossref","unstructured":"Hayes EB, Komar N, Nasci RS, Montgomery SP, O'Leary DR, Campbell GL. Epidemiology and dynamics of transmission of West Nile virus disease. Emerg Infect Dis.\u20082005;11:1167\u20131173","DOI":"10.3201\/eid1108.050289a"},{"key":"2021120820135731100_R3","doi-asserted-by":"crossref","unstructured":"Alpert SG, Fergerson J, Noel LP. Intrauterine West Nile virus: ocular and systemic findings. Am J Ophthalmol.\u20082003;136:733\u2013735","DOI":"10.1016\/S0002-9394(03)00452-5"},{"key":"2021120820135731100_R4","doi-asserted-by":"crossref","unstructured":"Hayes EB, O'Leary DR. West Nile virus infection: a pediatric perspective. Pediatrics.\u20082004;113:1375\u20131381","DOI":"10.1542\/peds.113.5.1375"},{"key":"2021120820135731100_R5","unstructured":"Mathur A, Tandon HO, Mathur KR, Sarkari NB, Singh UK, Chaturvedi UC. Japanese encephalitis virus infection during pregnancy. Indian J Med Res.\u20081985;81:9\u201312"},{"key":"2021120820135731100_R6","doi-asserted-by":"crossref","unstructured":"Chaturvedi UC, Mathur A, Chandra A, Das SK, Tandon HO, Singh UK. Transplacental infection with Japanese encephalitis virus. J Infect Dis.\u20081980;141:712\u2013715","DOI":"10.1093\/infdis\/141.6.712"},{"key":"2021120820135731100_R7","doi-asserted-by":"crossref","unstructured":"Chye JK, Lim CT, Ng KB, Lim JM, George R, Lam SK. Vertical transmission of dengue. Clin Infect Dis.\u20081997;25:1374\u20131377","DOI":"10.1086\/516126"},{"key":"2021120820135731100_R8","unstructured":"Kerdpanich A, Watanaveeradej V, Samakoses R, et al. Perinatal dengue infection. Southeast Asian J Trop Med Public Health.\u20082001;32:488\u2013493"},{"key":"2021120820135731100_R9","unstructured":"Poli L, Chungue E, Soulignac O, Gestas P, Kuo P, Papouin-Rauzy M. Materno-fetal dengue. Apropos of 5 cases observed during the epidemic in Tahiti (1989) [in French]. Bull Soc Pathol Exot.\u20081991;84:513\u2013521"},{"key":"2021120820135731100_R10","doi-asserted-by":"crossref","unstructured":"Andersen AA, Hanson RP. Intrauterine infection of mice with St. Louis encephalitis virus: immunological, physiological, neurological, and behavioral effects on progeny. Infect Immun.\u20081975;12:1173\u20131183","DOI":"10.1128\/iai.12.5.1173-1183.1975"},{"key":"2021120820135731100_R11","doi-asserted-by":"crossref","unstructured":"Andersen AA, Hanson RP. Experimental transplacental transmission of St. Louis encephalitis virus in mice. Infect Imm.\u20081970;2:320\u2013325","DOI":"10.1128\/iai.2.3.320-325.1970"},{"key":"2021120820135731100_R12","doi-asserted-by":"crossref","unstructured":"Mathur A, Arora KL, Chaturvedi UC. Congenital infection of mice with Japanese encephalitis virus. Infect Immun.\u20081981;34:26\u201329","DOI":"10.1128\/iai.34.1.26-29.1981"},{"key":"2021120820135731100_R13","doi-asserted-by":"crossref","unstructured":"Julander JG, Winger QA, Olsen AL, Day CW, Sidwell RW, Morrey JD. Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival. Antiviral Res.\u20082005;65:79\u201385","DOI":"10.1016\/j.antiviral.2004.10.005"},{"key":"2021120820135731100_R14","unstructured":"Barnard BJ, Voges SF. Flaviviruses in South Africa: pathogenicity for sheep. Onderstepoort J Vet Res.\u20081986;53:235\u2013238"},{"key":"2021120820135731100_R15","doi-asserted-by":"crossref","unstructured":"Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol.\u20082000;38:1823\u20131826","DOI":"10.1128\/JCM.38.5.1823-1826.2000"},{"key":"2021120820135731100_R16","doi-asserted-by":"crossref","unstructured":"Martin DA, Noga A, Kosoy O, Johnson AJ, Petersen LR, Lanciotti RS. Evaluation of a diagnostic algorithm using immunoglobulin M enzyme-linked immunosorbent assay to differentiate human West Nile virus and St. Louis encephalitis virus infections during the 2002 West Nile virus epidemic in the United States. Clin Diagn Lab Immunol.\u20082004;11:1130\u20131133","DOI":"10.1128\/CDLI.11.6.1130-1133.2004"},{"key":"2021120820135731100_R17","doi-asserted-by":"crossref","unstructured":"Lanciotti RS, Kerst AJ. Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis encephalitis viruses. J Clin Microbiol.\u20082001;39:4506\u20134513","DOI":"10.1128\/JCM.39.12.4506-4513.2001"},{"key":"2021120820135731100_R18","doi-asserted-by":"crossref","unstructured":"Guarner J, Shieh WJ, Hunter S, et al. Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum Pathol.\u20082004;35:983\u2013990","DOI":"10.1016\/j.humpath.2004.04.008"},{"key":"2021120820135731100_R19","doi-asserted-by":"crossref","unstructured":"Correa-Villasenor A, Cragan J, Kucik J, O'Leary L, Siffel C, Williams L. The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention. Birth Defects Res A Clin Mol Teratol.\u20082003;67:617\u2013624","DOI":"10.1002\/bdra.10111"},{"key":"2021120820135731100_R20","doi-asserted-by":"crossref","unstructured":"Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of heart defects. Pediatrics.\u20082001;107(3). Available at: www.pediatrics.org\/cgi\/content\/full\/107\/3\/e32","DOI":"10.1542\/peds.107.3.e32"},{"key":"2021120820135731100_R21","unstructured":"Tinanoff N. The oral cavity. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17th ed. Philadelphia, PA: WB Saunders; 2004:1204\u20131216"},{"key":"2021120820135731100_R22","doi-asserted-by":"crossref","unstructured":"Siffel C, Correa A, Cragan J, Alverson CJ. Prenatal diagnosis, pregnancy terminations and prevalence of Down syndrome in Atlanta. Birth Defects Res A Clin Mol Teratol.\u20082004;70:565\u2013571","DOI":"10.1002\/bdra.20064"},{"key":"2021120820135731100_R23","doi-asserted-by":"crossref","unstructured":"de Rijk-van Andel JF, Arts WF, Hofman A, Staal A, Niermeijer MF. Epidemiology of lissencephaly type I. Neuroepidemiology.\u20081991;10:200\u2013204","DOI":"10.1159\/000110270"},{"key":"2021120820135731100_R24","doi-asserted-by":"crossref","unstructured":"Nellhaus G. Head circumference from birth to eighteen years. Pediatrics.\u20081968;41:106\u201314","DOI":"10.1542\/peds.41.1.106"},{"key":"2021120820135731100_R25","unstructured":"Thompson GH. The foot and toes. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17th ed. Philadelphia, PA: WB Saunders; 2004:2254\u20132261"},{"key":"2021120820135731100_R26","doi-asserted-by":"crossref","unstructured":"Ockerman PA. Incidence of glycogen storage disease in Sweden. Acta Paediatr Scand.\u20081972;61:533\u2013535","DOI":"10.1111\/j.1651-2227.1972.tb15940.x"},{"key":"2021120820135731100_R27","unstructured":"Bennett MJ. Abortion. In: Hacker NF, Moore GJ, eds. Essentials of Obstetrics and Gynecology. Philadelphia, PA: WB Saunders; 1998:477"},{"key":"2021120820135731100_R28","unstructured":"Hamilton BE, Martin JA, Sutton PD. Births: preliminary data for 2003. Natl Vital Stat Rep.\u20082004;53:1\u201317"},{"key":"2021120820135731100_R29","doi-asserted-by":"crossref","unstructured":"Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol.\u20082003;67:193\u2013201","DOI":"10.1002\/bdra.10012"},{"key":"2021120820135731100_R30","unstructured":"Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data.\u20082000;314:1\u201327"},{"key":"2021120820135731100_R31","doi-asserted-by":"crossref","unstructured":"Sherry B, Mei Z, Grummer-Strawn L, Dietz WH. Evaluation of and recommendations for growth references for very low birth weight (\u22641500 grams) infants in the United States. Pediatrics.\u20082003;111:750\u2013758","DOI":"10.1542\/peds.111.4.750"},{"key":"2021120820135731100_R32","doi-asserted-by":"crossref","unstructured":"Paisley JE, Hinckley AF, O\u2019Leary DR, et al. West Nile virus infection among pregnant women in a Northern Colorado community, 2003 to 2004. Pediatrics.\u20082006;117:814\u2013820","DOI":"10.1542\/peds.2005-1187"},{"key":"2021120820135731100_R33","doi-asserted-by":"crossref","unstructured":"Skupski DW, Eglinton GS, Fine AD, Hayes EB, O'Leary DR. West Nile virus during pregnancy: a case study of early second trimester maternal infection. Fetal Diagn Ther.\u20082006;21:293\u2013295","DOI":"10.1159\/000091359"},{"key":"2021120820135731100_R34","doi-asserted-by":"crossref","unstructured":"Pinon JM, Dumon H, Chemla C, et al. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol.\u20082001;39:2267\u20132271","DOI":"10.1128\/JCM.39.6.2267-2271.2001"},{"key":"2021120820135731100_R35","doi-asserted-by":"crossref","unstructured":"Lubchencho LO, Hansmen C. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics.\u20081966;37:403\u2013408","DOI":"10.1542\/peds.37.3.403"},{"key":"2021120820135731100_R36","doi-asserted-by":"crossref","unstructured":"Hayes E, Sejvar J, Zaki S, Lanciotti RS, Bode AV, Campbell GL. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis.\u20082005;11:1174\u20131179","DOI":"10.3201\/eid1108.050289b"},{"key":"2021120820135731100_R37","unstructured":"Centers for Disease Control and Prevention. Possible West Nile virus transmission to an infant through breast-feeding: Michigan, 2002. MMWR Morb Mortal Wkly Rep.\u20082002;51:877\u2013878"},{"key":"2021120820135731100_R38","doi-asserted-by":"crossref","unstructured":"Pilz DT, Quarrell OW. Syndromes with lissencephaly. J Med Genet.\u20081996;33:319\u2013323","DOI":"10.1136\/jmg.33.4.319"},{"key":"2021120820135731100_R39","doi-asserted-by":"crossref","unstructured":"Wright R, Johnson D, Neumann M, et al. Congenital lymphocytic choriomeningitis virus syndrome: a disease that mimics congenital toxoplasmosis or cytomegalovirus infection. Pediatrics.\u20081997;100(1). Available at: www.pediatrics.org\/cgi\/content\/full\/100\/1\/e9","DOI":"10.1542\/peds.100.1.e9"},{"key":"2021120820135731100_R40","doi-asserted-by":"crossref","unstructured":"Greenhow TL, Weintrub PS. Your diagnosis, please: neonate with hydrocephalus. Pediatr Infect Dis J.\u20082003;22:1099, 1111\u20131112","DOI":"10.1097\/01.inf.0000101782.55760.3c"},{"key":"2021120820135731100_R41","doi-asserted-by":"crossref","unstructured":"Naessens A, Jenum PA, Pollak A, et al. Diagnosis of congenital toxoplasmosis in the neonatal period: a multicenter evaluation. J Pediatr.\u20081999;135:714\u2013719","DOI":"10.1016\/S0022-3476(99)70090-9"},{"key":"2021120820135731100_R42","unstructured":"Sheinbergas MM, Verikene VV, Maslinskas VY, Lyubetsky VB. Specific immunofluorescent IgG, IgM, and IgA antibodies in lymphocytic choriomeningitis. Acta Virol.\u20081978;22:218\u2013224"},{"key":"2021120820135731100_R43","doi-asserted-by":"crossref","unstructured":"Scheuerle A, Covington D. Clinical review procedures for the Antiretroviral Pregnancy Registry. Pharmacoepidemiol Drug Saf.\u20082004;13:529\u2013536","DOI":"10.1002\/pds.971"},{"key":"2021120820135731100_R44","doi-asserted-by":"crossref","unstructured":"Van den Eeden SK, Karagas MR, Daling JR, Vaughan TL. A case-control study of maternal smoking and congenital malformations. Paediatr Perinat Epidemiol.\u20081990;4:147\u2013155","DOI":"10.1111\/j.1365-3016.1990.tb00630.x"},{"key":"2021120820135731100_R45","doi-asserted-by":"crossref","unstructured":"Krauss MJ, Morrissey AE, Winn HN, Amon E, Leet TL. Microcephaly: an epidemiologic analysis. Am J Obstet Gynecol.\u20082003;188:1484\u20131490","DOI":"10.1067\/mob.2003.452"},{"key":"2021120820135731100_R46","unstructured":"Centers for Disease Control and Prevention. Interim guidelines for the evaluation of infants born to mothers infected with West Nile virus during pregnancy. MMWR Morb Mortal Wkly Rep.\u20082004;53:154\u2013157"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/3\/e537\/1071319\/zpe0030600e537.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/3\/e537\/1071319\/zpe0030600e537.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T12:45:53Z","timestamp":1683377153000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/117\/3\/e537\/68638\/Birth-Outcomes-Following-West-Nile-Virus-Infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,3,1]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-2024","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.10354.467842","asserted-by":"object"}]},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,1]]}}}